Delivery Order SPE2DB22D2206-SPE2DB24FJA80
- Not listed
- This federal contract award, valued at $3,044.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 units of chorionic gonad, a medical product, with a final completion date of April 29, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to supply 10,000 units of Chorionic Gonad, a pharmaceutical product. The $12,034.01 award has a completion date of March 5, 2024 and was issued as part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp to deliver a wide range of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $5,134.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 10,000 units of chorionic gonad, a medical product. The contract is not set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of 10,000 units of Chorionic Gonad, a medical product, to the Defense Logistics Agency (DLA), a defense agency. The firm fixed-price contract has a ceiling value of $8,374.87 and a completion date of May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp holds a significant...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 10,000 units of Chorionic Gonad with a potential value of $8,113.20. The contract has a completion date of February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is the prime contractor on this delivery order, which is issued under a larger indefinite...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,199.06 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FEGU5) is for the procurement of 10,000 units of CHORIONIC GONAD, with a completion date of April 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,880.53, is for the delivery of 10,000 units of Chorionic Gonad, a medical product. The contract has a completion date of December 4, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in the distribution of...
- This federal contract award, SPE2DB22D1106|SPE2DB24FFKK5, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The firm-fixed-price Delivery Order, valued at $8,583.34, is for the supply of 10,000 unit vials of Chorionic Gonad, a pharmaceutical product. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,135.40, is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of medications, devices, and critical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order (DO) valued at $3,193.80 for the provision of pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FJA80Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 10,000 units of chorionic gonad, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order contract is valued at $3,783.72 and runs through July 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care supplies. This delivery order contract appears to be part of that larger IDC vehicle. There is no set-aside designation mentioned for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/3/24 |